GZYJPCO(SH:603058)2025-01-21 10:45Financial Performance Forecast - The company expects a net profit attributable to shareholders of approximately CNY 172 million to CNY 202 million for 2024, representing a year-on-year increase of 71.74% to 101.69%[2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is estimated to be around CNY 156 million to CNY 186 million, reflecting a year-on-year growth of 64.95% to 96.67%[6]. - The previous year's net profit attributable to shareholders was CNY 100.15 million, with a net profit of CNY 94.58 million after deducting non-recurring gains and losses[8]. Revenue Growth Expectations - The company anticipates a significant increase in revenue from regulated pharmaceutical products, expected to grow by over 60% compared to the previous year[10]. - The company has seen growth in its cigarette label printing business outside Guizhou province in 2024[10]. Profitability and Market Impact - The company did not achieve profitability in Q2 2023 due to the impact of upgrading cigarette label QR codes, which is not expected to affect 2024[10]. - The fair value changes from private equity investments are expected to increase due to fluctuations in the secondary market[10]. Performance Forecast Validity - The performance forecast has not been audited by a registered accountant[3]. - There are currently no major uncertainties that could affect the accuracy of the performance forecast[11]. - The forecast data is preliminary and subject to change based on the audited annual report to be released later[12].